MTHFR and colorectal carcinoma: According to the inclusion/exclusion criteria, data from 21 studies that investigated the association between MTHFR C677T or A1298C polymorphisms and response to fluoropyrimidine-based chemotherapy in CRC patients were collected for the meta-analysis [12–32].